Cargando…

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis

BACKGROUND: Enhancer of zeste homologue 2 (EZH2) is a member of the Polycomb group of genes that is involved in epigenetic silencing and cell cycle regulation. METHODS: We studied EZH2 expression in 409 patients with colorectal cancer stages II and III. The patients were included in a randomised stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fluge, Ø, Gravdal, K, Carlsen, E, Vonen, B, Kjellevold, K, Refsum, S, Lilleng, R, Eide, T J, Halvorsen, T B, Tveit, K M, Otte, A P, Akslen, L A, Dahl, O
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768450/ https://www.ncbi.nlm.nih.gov/pubmed/19773751 http://dx.doi.org/10.1038/sj.bjc.6605333

Ejemplares similares

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
por: Myklebust, M P, et al.
Publicado: (2012)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays
por: Knutsvik, Gøril, et al.
Publicado: (2014)

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.
por: Pujol, J. L., et al.
Publicado: (1996)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
por: Cheang, Maggie C. U., et al.
Publicado: (2009)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Kruse, Arnold-Jan, et al.
Publicado: (2004)

Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study
por: Chen, Ying, et al.
Publicado: (2014)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Ki67 Antigen as a Predictive Factor for Prognosis of Sinonasal Mucosal Melanoma
por: Kim, Dong-Kyu, et al.
Publicado: (2008)

CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)

Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis
por: Liu, Yifei, et al.
Publicado: (2017)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
por: M. Lopes, José, et al.
Publicado: (1998)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Circulating tumor cells correlating with Ki-67 predicts the prognosis of bladder cancer patients
por: Liu, Jie, et al.
Publicado: (2022)

Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022)

Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women
por: Agboola, Ayodeji O. J., et al.
Publicado: (2013)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993)

Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas
por: Ahmed, Shatha Th, et al.
Publicado: (2018)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer
por: Aziz, Sura, et al.
Publicado: (2016)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Combined Ki67 and ERCC1 for prognosis in non-keratinizing nasopharyngeal carcinoma underwent chemoradiotherapy
por: Lu, Ying, et al.
Publicado: (2017)

Expressions of Topo IIα and Ki67 in breast cancer and its clinicopathologic features and prognosis
por: Sun, Guangyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5ngquha2bk5j8oc7b75iq4eor9